Crossmark

Survey of incidence, lifetime prevalence, and treatment of self-reported vulvovaginal candidiasis, United States, 2020

Published Online: 2022-05-10

Published Print: 2022-12

Authors

Benedict, Kaitlin

Singleton, Alyson L.

Jackson, Brendan R.

Molinari, Noelle Angelique M.
License Information

Text and Data Mining valid from 2022-05-10

Version of Record valid from 2022-05-10
More Information

Article History

Received: 13 September 2021

Accepted: 27 April 2022

First Online: 10 May 2022

Declarations

:

: Methods were carried out in accordance with relevant guidelines and regulations. CDC licensed this data from Porter Novelli. While Porter Novelli and Ipsos are not subject to CDC Institutional Board review, they do adhere to all professional standards and codes of conduct set forth by the ESOMAR Code of Conduct (ExternalRef removed) and the Insights Association (ExternalRef removed). Respondents were informed that their answers were being used for market research and they may refuse to answer any question at any time. No personal identifiers were included in the data file provided to CDC.

: Not applicable.

: The authors declare that they have no competing interests.

: The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention.

Document is current